Bagsværd, Denmark, 20 September 2024 – Novo Nordisk today announced headline results from a phase 2a clinical trial with monlunabant, a small molecule oral cannabinoid receptor 1 (CB1 ...

PITTSBURGH - Lipella Pharmaceuticals Inc. (NASDAQ:LIPO), a clinical-stage biotechnology company, has shared promising early results from its Phase 2a clinical trial of LP-310, an investigational ...

(NASDAQ:ALGS), a biopharmaceutical company specializing in liver and viral diseases, is set to release topline results from its Phase 2a HERALD study of ALG-055009 on Thursday. The study evaluates ...

Ami Fadia has given his Buy rating due to a combination of factors surrounding the promising early results from Immuneering’s phase 2a trial data. The initial outcomes for IMM-1-104 in ...

What is the moon phase today? Today, Sept. 27, 2024, the moon is 24 days old and is in the Waning Crescent phase of its lunar cycle. It is 23% illuminated. Moon phases reveal the passage of time ...

Lee, H.-L. Carini, John P. Baxter, David V. Henderson, W. and Grüner, G. 2000. Quantum-Critical Conductivity Scaling for a Metal-Insulator Transition. Science, Vol ...

Ah, the honeymoon phase—that initial stage of a romantic relationship that has us walking around like real-life heart-eyes emojis. It can feel good, and some may even say orgasmic, given that ...

There are two ways to figure out which phase of the Moon you were born under. The first and easiest way is to enter your birth time, date, and location into a free birth chart calculator that ...

(RTTNews) - Immuneering Corp. (IMRX) announced positive initial response data from the first five patients treated with IMM-1-104 in combination with modified ...

today announced positive topline results from the Phase 2a HERALD study of ALG-055009, a thyroid hormone receptor beta (THR-β) agonist, in metabolic-dysfunction associated steatohepatitis (MASH ...